Cancer's Next Big Thing -- Immunotherapy

December 15, 2014 4:45 PM

3 0

The headlines have been coming all year from some of the biggest names in cancer drug discovery and development -- from Merck, Bristol-Myers Squibb and AstraZeneca. And just last month, data from Roche's advanced bladder cancer study lit up the international medical community, pointing toward what could be the first major breakthrough in over 30 years for this dangerous cancer.

The big story here, of course, and the hope for cancer patients everywhere, is immunotherapy. Also known as biological therapy, or biotherapy, immunotherapies use the patient's own immune system to fight cancer, either by stimulating the immune system to attack cancer cells or by providing a patient...

Read more

To category page

Loading...